TY - JOUR AU - Gao, Wei-Zhen AU - Guo, Lie-Mei AU - Xu, Tian-Qi AU - Yin, Yu-Hua AU - Jia, Feng PY - 2018 DA - 2018/12/20 TI - Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients JO - Journal of Translational Medicine SP - 368 VL - 16 IS - 1 AB - Glioblastoma multiform (GBM) is a devastating brain tumor with maximum surgical resection, radiotherapy plus concomitant and adjuvant temozolomide (TMZ) as the standard treatment. Diverse clinicopathological and molecular features are major obstacles to accurate predict survival and evaluate the efficacy of chemotherapy or radiotherapy. Reliable prognostic biomarkers are urgently needed for postoperative GBM patients. SN - 1479-5876 UR - https://doi.org/10.1186/s12967-018-1744-8 DO - 10.1186/s12967-018-1744-8 ID - Gao2018 ER -